Genengnews published an interesting article on the Top 25 mergers and acquisitions (M&A) that occurred in the pharmaceutical world this year. There was a wide variety of purchases ranging in price, technology and geography. What makes this article stand out is the detail it goes into on each M&A, sharing detailed payment financials and deal status. It is also important also to know that the list does not include M&A where the values were not disclosed to the public. To see the full list and the rest of the article click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.